International Journal of Environmental Research and Public Health · 2020 · 42 citations · 38 references
NutritionT2d Health ManagementObesityMetabolic SyndromeBody CompositionDiabetes EpidemiologyPublic HealthDyslipidemiaHealth SciencesDiabetes ManagementHealth PolicyType 2Glycemic ControlEpidemiologyLipid ProfilesHealth ManagementGlobal HealthDiabetesDiabetes Mellitus
Glycosylated hemoglobin (HbA1c) was the best indicator of glycemic control, which did not show the dynamic relationship between glycemic control and lipid profiles. In order to guide the health management of Type 2 diabetes (T2D), we assessed the levels of lipid profiles and fasting plasma glucose (FPG) and displayed the relationship between FPG control and lipid profiles. We conducted a cross-sectional study that included 5822 participants. Descriptive statistics were conducted according to gender and glycemic status respectively. Comparisons for the control of lipid profiles were conducted according to glycemic control. Four logistic regression models were generated to analyze the relationship between lipid profiles and glycemic control according to different confounding factors. The metabolic control percentage of FPG, triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) was 27.50%, 73.10%, 28.10%, 64.20% and 44.80% respectively. In the fourth model with the most confounding factors, the odds ratios (ORs) and 95% confidence intervals (CIs) of TG, TC, LDL-C and HDL-C were 0.989 (0.935, 1.046), 0.862 (0.823, 0.903), 0.987 (0.920, 1.060) and 2.173 (1.761, 2.683). TC and HDL-C were statistically significant, and TG and LDL-C were not statistically significant with adjustment for different confounding factors. In conclusion, FPG was significantly associated with HDL and TC and was not associated with LDL and TG. Our findings suggested that TC and HDL should be focused on in the process of T2D health management.
38
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano, Ian Graham, Guy De Backer et al. · European Heart Journal · 2016 · 3.1K citations · Full text
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse et al. · Diabetes Care · 2014 · 3K citations
American Diabetes Association, Metabolic Syndrome, Non-pharmacological Intervention +18
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano, Ian Graham, Guy De Backer et al. · Atherosclerosis · 2016 · 1.6K citations · Full text
Lipid Disorder, Preventive Medicine, Cardiovascular Disease +7
Endocrine Practice · 2007 · 698 citations
Silvio E. Inzucchi, Richard M. Bergenstal, John B. Buse et al. · Diabetologia · 2015 · 684 citations · Full text
American Diabetes Association, Metabolic Syndrome, Diabetes Management +10